Strong Buy Biotech Stocks Direct

According to TipRanks and Yahoo Finance , the following large-cap biotech stocks currently hold a consensus rating: Gilead Sciences (GILD) Regeneron Pharmaceuticals (REGN) BioNTech (BNTX) Insmed Incorporated (INSM) IQVIA Holdings (IQV) Emerging Growth & Specialized Picks

These stocks have received specific "Strong Buy" ratings or upgrades from major financial institutions in late April 2026: strong buy biotech stocks

: Upgraded to Strong Buy by Truist Financial and BTIG Research . According to TipRanks and Yahoo Finance , the

: Raised to Strong Buy by HC Wainwright . According to TipRanks and Yahoo Finance

: Rating increased to Strong Buy at Truist Financial.

Several biotechnology companies have recently earned ratings from analysts as of April 28, 2026. These ratings are often driven by positive clinical trial progress, strategic acquisitions, or analyst upgrades following strong performance. Latest Analyst "Strong Buy" Upgrades